For example: Semaglutide for diabetes (Ozempic) typically starts at 0.25 mg weekly for 4 weeks, then 0.5 mg weekly, potentially increasing to 1 mg weekly Semaglutide for weight management (Wegovy) follows a different schedule, starting at 0.25 mg and increasing through 0.5 mg, 1.0 mg, 1.7 mg to a maintenance dose of 2.4 mg weekly For diabetes treatment, your healthcare team will typically review your HbA1c after about 3 months
If symptoms persist beyond 12 weeks despite dietary adjustments, your semaglutide formulation or dose timing should be evaluated by a PlexusDx clinician
Regular monitoring and clinical assessment are key to find the best schedule
Hence, these contribute to the reasons for the current inconsistencies in IGF-1 measurements
Prescription GLP-1 receptor agonists produce sustained, supraphysiologic levels of GLP-1 activityfar exceeding what dietary modifications can achieve